<DOC>
	<DOCNO>NCT01373502</DOCNO>
	<brief_summary>The purpose study demonstrate non-inferiority term safety efficacy DES Limus Carbostent compare Taxus Liberté treat de-novo atherosclerotic lesion native coronary artery .</brief_summary>
	<brief_title>International Randomized Comparison Between DES Limus Carbostent Taxus Drug Eluting Stents Treatment De-novo Coronary Lesions</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Age ≥ 18 year Patient eligible percutaneous coronary intervention ( PCI ) surgical revascularization ( CABG ) Patient informed nature study agree provision provide write informed consent approve Ethical Committee respective clinical site Patients clinical evidence ischemic heart disease and/or positive functional study ( e.g . stress test ) ; document stable ( CCS IIV ) unstable angina pectoris ( Braunwald class III B C ) document silent ischemia LVEF &gt; 30 % Requires treatment single de novo lesion native coronary artery one two different major epicardial vessel ( LAD , LCX RCA ) . The second lesion must fit inclusion/exclusion criterion must treat study stent first lesion Target lesion locate target vessel diameter range 3.0 3.75 mm Target lesion diameter stenosis &gt; 50 % &lt; 100 % visual estimate , TIMI flow ≥ 1 The target lesion must appropriately cover ( margin 2.5 mm side stent ) one study stent ( DES Limus Carbostent Taxus Liberté , accord randomization arm ) . Any occurred dissection target vessel must treat additional stent ( DES Limus Carbostent Taxus Liberté , accord randomization arm ) Patient underwent BMS implantation 6 month enrolment DES implantation 1 year enrolment vessel . Female childbearing potential lactating Known sensitivity sirolimus , paclitaxel , polymeric matrix , stainless steel cobalt chromium Acute Qwave non Qwave myocardial infarction within 72 hour , present CK elevation great 2 time upper limit normal associate elevated CKMB Cardiogenic shock Cerebrovascular accident within past 6 month Acute chronic renal dysfunction ( define creatinine great 2.0 mg/dl ) Contraindication aspirin clopidogrel Thrombocytopenia ( platelet count le 100,000/mm³ ) Active gastrointestinal bleeding within past 3 month Known bleed hypercoagulable disorder Prior anaphylactic reaction contrast agent contrast sensitivity control premedication Currently immunosuppressant therapy Currently , treat either Rapamune paclitaxel within 12 month procedure Active infection Comorbidities could interfere completion study procedure , life expectancy le 1 year ; Participating another investigational drug device trial complete primary endpoint would interfere endpoint study Patient underwent coronary revascularization vessel within 30 day Patient underwent target vessel revascularization within 6 month Target vessel prior stent placement Presence two lesion locate vascular territory ( major epicardial vessel ) Prior coronary brachytherapy There plan target lesion treatment technique predilatation balloon angioplasty Treatment two lesion require time enrolment , plan within 30 day follow enrolment Any plan surgery within 6 month index procedure Left main disease great 50 % diameter stenosis Significant ( &gt; 50 % ) stenosis proximal distal target lesion might require revascularization impede run Heavily calcify vessel and/or lesion successfully predilated Target lesion locate supplied arterial venous bypass graft Ostial target lesion lesion locate within 2 mm bifurcation Target lesion involve side branch &gt; 2.0 mm diameter ostial disease Target lesion TIMI 0 flow Target vessel angiographically visible thrombus unsuitable proper stent delivery deployment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>